V-Go device — Medical Mutual
Continuous insulin infusion therapy for diabetes mellitus (type 1 or insulin dependent type 2)
Initial criteria
- Patient age ≥ 18 years; AND
- Patient requires continuous subcutaneous infusion of either 20 Units, 30 Units, or 40 Units of basal insulin in a 24-hour time period AND on-demand dosing of up to 36 Units of bolus insulin in a 24-hour time period; AND
- Patient must be using a rapid-acting insulin product (U-100 only) in the device; AND
- Patient has been using multiple doses of insulin injections a day (3 injections daily or more); AND
- Patient has worked with a provider to adjust dose of insulin for at least 6 months and failed to meet glucose goals; AND
- Patient does not need to make regular adjustments or modifications to their basal rate during a 24-hour period, OR patient’s amount of bolus insulin used does not require adjustments of less than 2 unit increments; AND
- Patient meets ONE of the following while on insulin: HbA1c > 7%; OR history of recurring hypoglycemia; OR wide fluctuations in blood glucose before mealtime; OR dawn phenomenon with fasting blood sugars frequently exceeding 200 mg/dL; OR history of severe glycemic excursions; AND
- Patient has tried and failed an external insulin pump (failure such as: blood glucose control cannot be maintained on an external pump OR member has barriers that cannot allow the use of an external pump) [documentation required]; AND
- Patient’s total daily insulin requirement does not exceed 76 units.
Reauthorization criteria
- Patient age ≥ 18 years; AND
- Patient requires continuous subcutaneous infusion of either 20 Units, 30 Units, or 40 Units of basal insulin in a 24-hour time period AND on-demand dosing of up to 36 Units of bolus insulin in a 24-hour time period; AND
- Patient is using a rapid-acting insulin product (U-100 only) in the device; AND
- Patient’s total daily insulin requirement does not exceed 76 units; AND
- Patient is currently on the V-Go device OR member has tried and failed an external insulin pump (failure such as: blood glucose control cannot be maintained on an external pump OR member has barriers that cannot allow the use of an external pump) [documentation required].
Approval duration
1 year initial, 1 year reauth